Home  /  Resource Library  /  Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients

Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients

Study examined the effect of Ibrutinib in enhancing CAR T cell production in patients with CLL.